Genetic Counselors: An Important Resource for Families following a Young Sudden Cardiac Death

Academic Forensic Pathology

Volumn 3, Issue 2, 2013, Pages 183-190

  MacLeod, Heather ^a   Demo, Erin ^b   Honeywell, Christina ^c   Rutberg, Julie ^d  

^a National Society of Genetic Counselors and scientific advisor to the SADS foundation   (United States)

^b SIBLEY HEART CENTER CARDIOLOGY   (United States)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Forensic pathology; Genetic counseling; Postmortem genetic testing; Sudden cardiac death

Indexed keywords

EID: 84969439192     PISSN: None     EISSN: 19253621     Source Type: Journal    
DOI: 10.23907/2013.023     Document Type: Article

References (30)

1. Ingles J., Yeates L., Semsarian C., The emerging role of the cardiac genetic counselor. Heart Rhythm. 2011 Dec; 8(12): 1958–62.
2. McCarthy Veach P., LeRoy B., Bartels D., Facilitating the genetic counseling process; a practice manual. New York: Springer; 2003. 320 p.
3. Demo E.M., Skrzyna C., Baxter S., Genetic counseling and testing for hypertrophic cardiomyopathy: the pediatric perspective. J Cardiovasc Transl Res. 2009 Dec; 2(4): 500–7.
4. Puranik R., Chow C.K., Duflou J.A., Sudden death in the young. Heart Rhythm. 2005 Dec; 2(12): 1277–82.
5. Hershberger R., Lindenfeld J., Mestroni L., Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline. J Card Fail. 2009 Mar; 15(2): 83–97.
6. Hiratzka L.F., Bakris G.L., Beckman J.A., 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Catheter Cardiovasc Interv. 2010 Aug 1; 76(2): E43–86.
7. American College of Cardiology Foundation/American Heart Association Task Force on Practice, American Association for Thoracic Surgery, American Society of Echocardiography, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2011 Dec; 142(6): e153–203.
8. Lin A.E., Salbert B.A., Belmont J., Smoot L., Total is more than the sum of the parts: phenotyping the heart in cardiovascular genetics clinics. Am J Med Genet A. 2004 Dec 1; 131(2): 111–4.
9. Elger B.S., Michaud K., Mangin P., When information can save lives: the duty to warn relatives about sudden cardiac death and environmental risks. Hastings Cent Rep. 2010 May-Jun; 40(3): 39–45.
10. Godard B, Schmidtke J., Cassiman J.J., Aymé S., Data storage and DNA banking for biomedical research: informed consent, confidentiality, quality issues, ownership, return of benefits. A professional perspective. Eur J Hum Genet. 2003 Dec; 11 Suppl 2: S88–122.
11. Behr E., Wood D.A., Wright M., Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet. 2003 Nov 1; 362(9394): 1457–9.
12. Ingles J., Semsarian C., Sudden cardiac death in the young: a clinical genetic approach. Intern Med J. 2007 Jan; 37(1): 32–7.
13. Gollob M.H., Blier L., Brugada R., Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol. 2011 Mar-Apr; 27(2): 232–45.
14. Ackerman M.J., Priori S.G., Willems S., HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies. Heart Rhythm. 2011 Aug; 8(8): 1308–39.
15. Middleton O., Baxter S., Demo E., National Association of Medical Examiners position paper: Retaining postmortem samples for genetic testing. Acad Forensic Pathol. 2013 Jun; 3(2): 198–201.
16. Carturan E., Tester D.J., Brost B.C., Postmortem genetic testing for conventional autopsy-negative sudden unexplained death: an evaluation of different DNA extraction protocols and the feasibility of mutational analysis from archival paraffin-embedded heart tissue. Am J Clin Pathol. 2008 Mar; 129(3): 391–7.
17. McNally E., MacLeod H., and Dellefave L., Arrhythmogenic right ventricular dysplasia/cardiomypathy, autosomal dominant. In: Pagon R.A., Bird T.D., Dolan C.R., Stephens K., Adam M.P., editors. SourceGeneReviews” [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. 2005 Apr 18 [updated 2009 Oct 13].
18. Thiene G., Corrado D., Basso C., Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis. 2007 Nov 14; 2: 45.
19. GeneDx: DNA diagnostic experts [Internet]. Gaithersburg (MD): GeneDX; c2013 [cited 2013 Apr 5]. Available from: http://www.genedx.com.
20. Transgenomic: advancing personalized medicine [Internet]. Omaha: Transgenomic Inc.; c1997–2012 [cited 2013 Apr 5]. Available from: http://www.transgenomic.com.
21. Fowler S.J., Priori S.G., Clinical spectrum of patients with a Brugada ECG. Curr Opin Cardiol. 2009 Jan; 24(1): 74–81.
22. Ambry Genetics [Internet]. Aliso Viejo (CA): Ambry Genetics Corp.; c2013 [cited 2013 Apr 5]. Available from: http://www.ambrygen.com.
23. Liu N., Ruan Y., Priori S.G., Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis. 2008 Jul-Aug; 51(1): 23–30.
24. Hershberger R.E., Kushner J.D., Parks S.B., Dilated cardiomyopathy overview. In: Pagon R.A., Bird T.D., Dolan C.R., Stephens K., Adam M.P., editors. SourceGeneReviews” [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. 2007 Jul 27 [updated 2009 Mar 19].
25. Marian A.J., Roberts R., Molecular genetics of hypertrophic cardiomyopathy. Annu Rev Med. 1995; 46: 213–22.
26. Crotti L., Celano G., Dagradi F., Schwartz P.J., Congenital long QT syndrome. Orphanet J Rare Dis. 2008 Jul 7; 3: 18.
27. Milewicz D., Regalado E., Thoracic aortic aneurysms and aortic dissections. In: Pagon R.A., Bird T.D., Dolan C.R., Stephens K., Adam M.P., editors. SourceGe-neReviews” [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. 2003 Feb 13 [updated 2012 Jan 12].
28. Cirino A., Ho C., Familial hypertrophic cardiomyopathy overview. In: Pagon R.A., Bird T.D., Dolan C.R., Stephens K., Adam M.P., editors. SourceGeneReviews” [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. 2008 Aug 05 [updated 2011 May 17].
29. Ashley E.A., Hershberger R.E., Caleshu C., Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2012 Jul 3; 126(1): 142–57.
30. Perez M.V., Kumarasamy N.A., Owens D.K., Cost-effectiveness of genetic testing in family members of patients with long-QT syndrome. Circ Cardiovasc Qual Outcomes. 2011 Jan 1; 4(1): 76–84.